Dual Implants for Hiv Treatment and Prevention Tender, USA - 78572362

Procurement Summary

Country : USA

Summary : Dual Implants for Hiv Treatment and Prevention

Deadline : 24 Feb 2023

Other Information

Notice Type : Tender

TOT Ref.No.: 78572362

Document Ref. No. : 75D30123-R-72588

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Login to see details

Tender Details

Description

The Center for Disease Control and Prevention (CDC), National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), the Antiretroviral Prophylaxis Team at Division of HIV Prevention (DHP), Laboratory Branch intends to award a sole source contract to the University of North Carolina/North Carolina State University (UNC/NCSU) Joint Department of Biomedical Engineering, 116 Manning Drive, 9212B Mary Ellen Jones Building, Chapel Hill, NC 27599-7362 for the purchase of an implant carrier that can accommodate two (2) antiretroviral drugs and can be used to prevent or treat HIV infection.

The statutory authority for this sole source acquisition is 41 U.S.C 3304(a)(1) in accordance with FAR Part 6.302-1- only one responsible source and no other supplies or services will satisfy the agency requirement. The NAICS code for this procurement is 339112 Surgical and Medical Instrument Manufacturing.

The purpose of this acquisition is to purchase an implant carrier that contains polymeric solid implants (PSIs) with Rilpivirine and Cabotegravir or an analogue of Cabotegravir. The contractor shall design an implant carrier that can accommodate the PSIs, investigate the performance of the implant carrier under laboratory conditions, and perform studies in mice to define implant integrity, body migration, and drug concentrations in blood plasma. The University of North Carolina/North Carolina State University Joint Department of Biomedical Engineering (UNC/NCSU-BME) has already designed polymeric solid implants containing anti-HIV drugs. These pellet-type solid implants meet the Government-s target product profile since they are solid, safe, and have been formulated with the two anti-HIV drugs that are required for this work (Rilpivirine and Cabotegravir or analogues of Cabotegravir). UNC/NCSU is the only company that has solid implants with Rilpivirine. Additionally, UNC-s solid implants do not require multiple administrations. Therefore, UNC/NCSU ...
Active Contract Opportunity
Notice ID : 75D30123-R-72588
Related Notice
Department/Ind. Agency : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier : CENTERS FOR DISEASE CONTROL AND PREVENTION
Office : CDC OFFICE OF ACQUISITION SERVICES
General Information
Contract Opportunity Type: Presolicitation (Original)
All Dates/Times are: (UTC-05:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Feb 09, 2023 01:46 pm EST
Original Response Date: Feb 24, 2023 05:00 pm EST
Inactive Policy: Manual
Original Inactive Date: Jun 01, 2023
Initiative: None

Classification
Original Set Aside:
Product Service Code: 6515 - MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES
NAICS Code: 339112 - Surgical and Medical Instrument Manufacturing

Place of Performance: Chapel Hill, NC 27599 USA

Documents

 Tender Notice